Schedule of Investments ─ IQ Healthy Hearts ETF

January 31, 2024 (unaudited)

	Shares		Value
Common Stocks — 99.7%
Australia — 0.5%
Ramsay Health Care Ltd.		1,281	$	43,382
Canada — 1.1%
George Weston Ltd.		347		44,490
Loblaw Cos. Ltd.		467		46,961
Total Canada				91,451
China — 0.4%
China Traditional Chinese Medicine Holdings Co., Ltd.		86,128		32,943
Denmark — 5.2%
Novo Nordisk A/S, Class B		3,968		448,047
Germany — 2.0%
adidas AG		356		68,106
Fresenius SE & Co. KGaA		1,367		38,786
Puma SE		678		27,691
Siemens Healthineers AG		742		41,799
Total Germany				176,382
Ireland — 0.5%
Glanbia PLC		2,475		44,467
Italy — 0.5%
Moncler SpA		741		46,121
Japan — 2.1%
Asahi Intecc Co., Ltd.		2,167		41,976
Nihon Kohden Corp.		1,698		52,378
Sawai Group Holdings Co., Ltd.		1,261		48,301
Shimano, Inc.		275		40,175
Total Japan				182,830
Malaysia — 0.5%
IHH Healthcare Bhd		33,741		43,514
Netherlands — 0.5%
Basic-Fit NV*(a)		1,418		41,496
Spain — 0.5%
Fluidra SA		2,001		43,732
Sweden — 0.9%
Axfood AB		1,676		42,709
Thule Group AB		1,514		38,992
Total Sweden				81,701
Switzerland — 5.5%
Novartis AG		4,240		441,867
On Holding AG, Class A*		1,467		38,964
Total Switzerland				480,831
Taiwan — 0.9%
Feng TAY Enterprise Co., Ltd.		7,298		37,773
Giant Manufacturing Co., Ltd.		7,614		43,422
Total Taiwan				81,195
Thailand — 1.0%
Bangkok Dusit Medical Services PCL		56,472		43,773
Bumrungrad Hospital PCL		6,831		46,211
Total Thailand				89,984
United Kingdom — 5.5%
AstraZeneca PLC		3,250		434,564
Frasers Group PLC*		3,816		39,362
Total United Kingdom				473,926
United States — 72.1%
Abbott Laboratories		4,057		459,050
Acadia Healthcare Co., Inc.*		568		46,656
Alphabet, Inc., Class A*		3,053		427,725
Apple, Inc.		2,197		405,127
AtriCure, Inc.*		993		33,822

	Shares		Value
Common Stocks (continued)
United States (continued)
Boston Scientific Corp.*		3,270	$	206,860
Bristol-Myers Squibb Co.		4,560		222,847
Centene Corp.*		1,185		89,242
Cytokinetics, Inc.*		1,307		102,116
Deckers Outdoor Corp.*		66		49,746
Dick's Sporting Goods, Inc.		339		50,535
Edwards Lifesciences Corp.*		1,340		105,150
Elevance Health, Inc.		524		258,563
Eli Lilly & Co.		694		448,053
Encompass Health Corp.		631		44,826
Garmin Ltd.		345		41,224
General Mills, Inc.		1,300		84,383
Hayward Holdings, Inc.*		3,508		43,920
HCA Healthcare, Inc.		436		132,936
Inari Medical, Inc.*		708		40,321
Johnson & Johnson		2,737		434,909
Kellanova		781		42,768
LivaNova PLC*		947		46,100
Medtronic PLC		2,979		260,782
Merit Medical Systems, Inc.*		578		45,257
Molina Healthcare, Inc.*		129		45,981
NIKE, Inc., Class B		3,877		393,632
Peloton Interactive, Inc., Class A*		7,927		44,074
Pentair PLC		661		48,365
Penumbra, Inc.*		179		45,142
Pfizer, Inc.		13,683		370,536
Planet Fitness, Inc., Class A*		638		43,231
Pool Corp.(a)		118		43,807
Rhythm Pharmaceuticals, Inc.*		1,206		53,197
Sanofi SA		2,540		257,587
Select Medical Holdings Corp.		1,770		46,002
Shockwave Medical, Inc.*		238		53,847
Tenet Healthcare Corp.*		614		50,802
Topgolf Callaway Brands Corp.*		3,552		46,780
Under Armour, Inc., Class A*		5,439		41,445
United Therapeutics Corp.*		181		38,875
UnitedHealth Group, Inc.		763		390,458
Vail Resorts, Inc.		184		40,848
VF Corp.		2,518		41,446
YETI Holdings, Inc.*		993		43,662
Total United States				6,262,635
Total Common Stocks
(Cost $7,808,173)				8,664,637
Short-Term Investment — 0.0%(b)
Money Market Funds — 0.0%(b)
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares, 5.30%(c)
(Cost $1,978)		1,978		1,978
Total Investments — 99.7% (Cost $7,810,151)				8,666,615
Other Assets and Liabilities, Net — 0.3%				21,851
Net Assets — 100%			$	8,688,466

Schedule of Investments ─ IQ Healthy Hearts ETF (continued)

January 31, 2024 (unaudited)

			% of
Industry	Value		Net Assets
Health Care	$	6,087,458		70.1	%
Consumer Discretionary		1,302,532		15.0
Communication Services		427,725		4.9
Information Technology		405,127		4.6
Consumer Staples		305,778		3.5
Industrials		136,017		1.6
Money Market Funds		1,978		0.0	(b)
Total Investments	$	8,666,615		99.7	%
Other Assets and Liabilities, Net		21,851		0.3
Total Net Assets	$	8,688,466		100 .0%

*	Non-income producing securities.
(a)	All or a portion of the security was on loan. In addition, “Other Assets and Liabilities, Net” may include pending sales that are also on loan. The aggregate market value of securities on loan was $82,112; total market value of collateral held consisted of non-cash U.S. Treasury securities collateral having a value of $87,162.
(b)	Less than 0.05%.
(c)	Reflects the 1-day yield at January 31, 2024.

The following is a summary of the inputs used to value the Fund's investments as of January 31, 2024. For more information on the valuation techniques, and their aggregation into the levels used in the table below, please refer to the Fund's most recent semi-annual or annual financial statements.

Description	Level 1		Level 2		Level 3		Total
Asset Valuation Inputs
Investments in Securities:(d)
Common Stocks	$	8,664,637	$	—	$	—	$	8,664,637
Short-Term Investment:
Money Market Funds		1,978		—		—		1,978
Total Investments in Securities	$	8,666,615	$	—	$	—	$	8,666,615

(d) For a complete listing of investments and their countries, see the Schedule of Investments.

For the period ended January 31, 2024 the Fund did not have any transfers into or out of Level 3 within the fair value hierarchy